SEC Filings

Form 6-K
AURIS MEDICAL HOLDING AG filed this Form 6-K on 02/09/2018
Document Outline
Entire Document (2668.4 KB)
Subdocument 1 - 6-K - FORM 6-K
Page 1 - UNITED STATES
Page 2 - SIGNATURE
Page 3 - EXHIBIT INDEX
Subdocument 2 - EX-99.1 - EXHIBIT 99.1
Page 1 - Exhibit 99.1
Page 2 - Forward-looking Statements
Subdocument 3 - EX-99.2 - EXHIBIT 99.2
Page 1 - Exhibit 99.2
Page 2 - Agenda Item 1 is a conditional Agenda Item
Page 3 - N/A
Page 4 - N/A
Page 5 - Organizational Matters
Page 6 - Questions:
Page 7 - Einladung zur Ausserordentlichen Generalversammlung
Page 8 - Information betreffend bedingter Vollzug der Fusion:
Page 9 - * Allgemeiner Hinweis: Die Nichtdurchf hrung der Abstimmung zu Traktandum 1 (vgl. oben) hat zur Folg
Page 10 - Organisatorische Hinweise
Page 11 - Fragen:
Subdocument 4 - EX-99.3 - EXHIBIT 99.3
Page 1 - Exhibit 99.3
Page 2 - Table of Contents
Page 3 - N/A
Page 4 - Table of Annexes
Page 5 - Preamble
Page 6 - All shares in the Surviving Company are currently held by the Transferring Company.
Page 7 - Fusion
Page 8 - All assets and liabilities (debt) of the Transferring Company shall, by operation of law (universal
Page 9 - article 16 Merger Act, for inspection by their shareholders during at least 30 days prior to the res
Page 10 - As per completion of the Merger, the composition of the board of directors of the Surviving Company
Page 11 - The number of shares required in connection with the exchange to enable the allocation of a full num
Page 12 - No rights of holders of special rights, no equity interests without voting rights and no profit-shar
Page 13 - The individuals acting hereunder on behalf of the Surviving Company herewith confirm that the board
Page 14 - nach
Page 15 - Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of USD 1.0
Page 16 - the board of directors of the Transferring Company shall not consummate the Merger and, accordingly,
Page 17 - the Merger Agreement with the required quorum pursuant to article 18 (1) (a) Merger Act.
Page 18 - The shareholders of the Transferring Company, whether they are registered shareholders or shareholde
Page 19 - The Surviving Company and the Transferring Company will file the Merger Agreement and the merger res
Page 20 - This Merger Agreement may only be modified or amended by a document signed by all Parties. Any waive
Page 21 - If any provision of this Merger Agreement shall be held to be invalid, illegal or unenforceable for
Page 22 - The following annex shall form an integral part of this Merger Agreement:
Page 23 - This Merger Agreement (and with it the Merger) shall be considered to have been consummated as soon
Page 24 - Signatures
Page 25 - Annex 2.1 Audited Merger balance sheet of Transferring Company as of 30 September 2017
Subdocument 5 - EX-99.4 - EXHIBIT 99.4
Page 1 - Exhibit 99.4
Page 2 - Table of Contents
Page 3 - N/A
Page 4 - Table of Annexes
Page 5 - Preamble
Page 6 - OR
Page 7 - All shares of NewCo are currently held by AMHAG.
Page 8 - On 1 March 2017, AMHAG announced that it had received written notification from Nasdaq notifying AMH
Page 9 - As a result of the Merger, AMHAG will be merged into NewCo (i.e. all of AMHAG assets and liabilities
Page 10 - AMHAG and NewCo have agreed to a merger by absorption, in which all assets and liabilities of AMHAG
Page 11 - In connection with the completion of the transaction contemplated in the Merger Agreement, the artic
Page 12 - The Merger should not entail any Swiss withholding tax consequences for the Merging Companies.
Page 13 - Merger Act, the annual accounts and the annual reports of AMHAG for the last three business years, a
Page 14 - The board of directors of AMHAG and of NewCo have signed the Merger Agreement dated 9 February 2018.
Page 15 - the AMHAG shareholders shall be entitled to dividends in relation to the New AMHAG Shares from the d
Page 16 - The number of shares required in connection with the exchange to enable the allocation of a full num
Page 17 - In connection with the present Merger no duties in connection with article 14 (3) (g) Merger Act are
Page 18 - days, in the Swiss Official Gazette of Commerce, unless a specially licensed audit expert confirms i
Page 19 - In case of discrepancies between the German and the English version in this Merger Report, the Germa
Page 20 - N/A
Page 21 - Annex 1 Merger Agreement between AMHAG and NewCo dated 9 February 2017
Page 22 - Annex 2 Audited Merger balance sheet of AMHAG as of 30 September 2017
Subdocument 6 - EX-99.5 - EXHIBIT 99.5
Page 1 - Exhibit 99.5
Page 2 - N/A
Page 3 - N/A
Subdocument 7 - EX-99.6 - EXHIBIT 99.6
Page 1 - Exhibit 99.6
Page 2 - Report of the independent auditor
Page 3 - Opinion
Page 4 - AURIS MEDICAL HOLDING AG, ZUG
Subdocument 8 - EX-99.7 - EXHIBIT 99.7
Page 1 - Exhibit 99.7
Subdocument 9 - EX-99.8 - EXHIBIT 99.8
Page 1 - Exhibit 99.8
Page 2 - To the Board of Directors and Shareholders of Auris Medical Holding AG
Page 3 - Consolidated Statement of Profit or Loss and Other Comprehensive Loss
Page 4 - Consolidated Statement of Financial Position
Page 5 - Consolidated Statement of Changes in Equity
Page 6 - Consolidated Statement of Cash Flows
Page 7 - 1. Reporting entity
Page 8 - Income taxes
Page 9 - Foreign currency
Page 10 - Intangible assets
Page 11 - Financial instruments
Page 12 - Impairment of non-derivative financial assets
Page 13 - Employee benefits
Page 14 - Provisions
Page 15 - 5. Financial instruments and risk management
Page 16 - Credit risk
Page 17 - Interest rate risk
Page 18 - 8. Intangible assets
Page 19 - 11. Cash and cash equivalents
Page 20 - Authorized share capital
Page 21 - Measurement of fair values
Page 22 - 15. Accrued expenses
Page 23 - Benefit plans
Page 24 - Change in fair value of plan assets
Page 25 - Sensitivity analysis
Page 26 - N/A
Page 27 - N/A
Page 28 - 21. Loss per share
Page 29 - Controlled Equity OfferingSM
Page 30 - 25. Events after the balance sheet date
Page 31 - AURIS MEDICAL HOLDING AG, ZUG
Page 32 - Statutory Auditor s Report
Page 33 - Key Audit Matters
Page 34 - N/A
Page 35 - N/A
Page 36 - Other Information in the Annual Report
Page 37 - Auditor s Responsibilities for the Audit of the Consolidated Financial Statements
Page 38 - Consolidated Statement of Profit or Loss and Other Comprehensive Loss
Page 39 - Consolidated Statement of Financial Position
Page 40 - Consolidated Statement of Changes in Equity
Page 41 - Consolidated Statement of Cash Flows
Page 42 - 1. Reporting entity
Page 43 - Income taxes
Page 44 - Foreign currency
Page 45 - Intangible assets
Page 46 - Financial instruments
Page 47 - Impairment of non-derivative financial assets
Page 48 - Employee benefits
Page 49 - Provisions
Page 50 - 5. Financial instruments and risk management
Page 51 - Credit risk
Page 52 - Interest rate risk
Page 53 - 8. Intangible assets
Page 54 - 11. Cash and cash equivalents
Page 55 - Authorized share capital
Page 56 - Measurement of fair values
Page 57 - 15. Accrued expenses
Page 58 - Benefit plans
Page 59 - Change in fair value of plan assets
Page 60 - Sensitivity analysis
Page 61 - N/A
Page 62 - N/A
Page 63 - 21. Loss per share
Page 64 - Controlled Equity OfferingSM
Page 65 - 25. Events after the balance sheet date
Page 66 - AURIS MEDICAL HOLDING AG, ZUG
Page 67 - Report of the Statutory Auditor
Page 68 - Responsibility of the Board of Directors for the Financial Statements
Page 69 - Auditor s Responsibilities for the Audit of the Financial Statements
Page 70 - AURIS MEDICAL HOLDING AG, ZUG
Page 71 - AURIS MEDICAL HOLDING AG, ZUG
Page 72 - AURIS MEDICAL HOLDING AG, ZUG
Page 73 - AURIS MEDICAL HOLDING AG, ZUG
Page 74 - AURIS MEDICAL HOLDING AG, ZUG
Page 75 - AURIS MEDICAL HOLDING AG, ZUG
Page 76 - AURIS MEDICAL HOLDING AG, ZUG
Page 77 - AURIS MEDICAL HOLDING AG, ZUG
Page 78 - AURIS MEDICAL HOLDING AG, ZUG
Page 79 - N/A
Page 80 - Report of the Statutory Auditor
Page 81 - Opinion
Page 82 - AURIS MEDICAL HOLDING AG, ZUG
Page 83 - AURIS MEDICAL HOLDING AG, ZUG
Page 84 - AURIS MEDICAL HOLDING AG, ZUG
Page 85 - AURIS MEDICAL HOLDING AG, ZUG
Page 86 - AURIS MEDICAL HOLDING AG, ZUG
Page 87 - AURIS MEDICAL HOLDING AG, ZUG
Page 88 - AURIS MEDICAL HOLDING AG, ZUG
Page 89 - AURIS MEDICAL HOLDING AG, ZUG
Page 90 - N/A
Page 91 - N/A
Page 92 - N/A
Page 93 - N/A
Page 94 - N/A
Page 95 - N/A
Page 96 - N/A
Page 97 - N/A
Page 98 - N/A
Page 99 - N/A
Page 100 - N/A
Subdocument 10 - EX-99.9 - EXHIBIT 99.9
Page 1 - AURIS MEDICAL
Page 2 - Report of the statutory auditor
Page 3 - Opinion
Page 4 - Compensation Report of Auris Medical Holding AG
Page 5 - Role of the Compensation Committee
Page 6 - Role of Shareholders
Page 7 - N/A
Page 8 - Armando Anido, Director, Chairman of the Compensation Committee
Page 9 - N/A
Page 10 - N/A
Page 11 - Thomas Meyer, Founder, Chairman of the Board of Directors and Chief Executive Officer
Page 12 - Base Salary
Page 13 - in CHF
Subdocument 11 - EX-99.10 - EXHIBIT 99.10
Page 1 - Exhibit 99.10
Page 2 - N/A